BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38213209)

  • 1. Analysis of Correlation between Rab1A Expression and its Prognosis in Cancers: a Meta-Analysis.
    Wang J; Liao J; Liu J; Meng C; Liu B; Shao C
    Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pooled analysis of prognostic value and clinical significance of Rab1A expression in human solid tumors.
    Shao X; Cheng Z; Xu M; Tan Z; Gao L; Wang J; Zhou C
    Medicine (Baltimore); 2019 Dec; 98(50):e18370. PubMed ID: 31852145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis.
    Zhang D; Liu J; Zheng M; Meng C; Liao J
    World J Surg Oncol; 2022 Oct; 20(1):351. PubMed ID: 36309698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of CSN5 in patients with digestive system cancers: a systematic review and meta-analysis.
    Guo Y; Gao M; Yao Y; Li J; Chen X; Wang X; Chen Z; Yuan Y; Ma W
    BMC Cancer; 2022 Jul; 22(1):812. PubMed ID: 35870903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and clinicopathologic significance of PLIN2 in cancers: A systematic review with meta-analysis.
    Li ML; Luo HY; Quan ZW; Huang LT; Wang JH
    Int J Biol Markers; 2023 Mar; 38(1):3-14. PubMed ID: 36604990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer.
    Wang ZK; Cheng ZW; Chen SJ; Zhu XG; Gu YP; Yang XD; Sun L; Liu WT; Zhang YJ; Yuan JF; Tian KJ; Yao YZ; He SB
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4509-4517. PubMed ID: 30058685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis and implication of Rab1A in gastrointestinal relevant tumor.
    Xu M; Shao X; Kuai X; Zhang L; Zhou C; Cheng Z
    Sci Rep; 2019 Sep; 9(1):13384. PubMed ID: 31527621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis, Significance and Positive Correlation of Rab1A and p-S6K/Gli1 Expression in Gastric Cancer.
    Shao X; Cheng Z; Xu M; Mao J; Wang J; Zhou C
    Anticancer Agents Med Chem; 2019; 19(11):1359-1367. PubMed ID: 31038077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
    Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis value and positive association of Rab1A/IL4Rα aberrant expression in gastric cancer.
    Li H; Cheng Z; Jiang B; Shao X; Xu M
    Sci Rep; 2023 Apr; 13(1):6964. PubMed ID: 37117331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
    Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
    Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
    Hu L; Huang M; Yuan Q; Kong F
    Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
    Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
    Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis.
    Liu X; Ming X; Jing W; Luo P; Li N; Zhu M; Yu M; Liang C; Tu J
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
    Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J
    Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis.
    Li D; Wang R; Wu N; Yu Y
    Aging (Albany NY); 2022 Feb; 14(4):1797-1811. PubMed ID: 35183058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rab1A promotes cell proliferation and migration by upregulating Gli1 in colorectal cancer.
    Peng C; Li X; Ye Z; Wu W
    Sci Rep; 2021 Aug; 11(1):16243. PubMed ID: 34376787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of decreased NDRG1 expression in patients with digestive system cancers: A meta-analysis.
    Chen K; Liu XH; Wang FR; Liu HP; Huang ZP; Chen X
    Medicine (Baltimore); 2018 Oct; 97(41):e12455. PubMed ID: 30313035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.